Iovance Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 31.08 M | $109.09 M | 5.29% | 8.70% |
| MHR FUND MANAGEMENT LLC | 05/15/2026 | 28.97 M | $101.67 M | 0.00% | 8.11% |
| STATE STREET CORP | 05/15/2026 | 17.45 M | $61.24 M | -13.46% | 4.88% |
| 05/15/2026 | 16.62 M | $58.33 M | 100.00% | 4.65% | |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 13.69 M | $48.04 M | 211.22% | 3.83% |
| 05/08/2026 | 11.70 M | $41.07 M | 100.00% | 3.27% | |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 9.41 M | $33.04 M | 42.95% | 2.63% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 8.76 M | $30.75 M | 1.77% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 8.57 M | $30.10 M | 7.27% | 2.40% |
| INVENOMIC CAPITAL MANAGEMENT LP | 05/15/2026 | 8.50 M | $29.82 M | -28.96% | 2.38% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 8.49 M | $29.80 M | -40.54% | 2.38% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 8.02 M | $28.14 M | 109.32% | 2.24% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 6.35 M | $22.29 M | -10.78% | 1.78% |
| MORGAN STANLEY | 05/15/2026 | 6.20 M | $21.77 M | -32.53% | 1.74% |
| JANE STREET GROUP, LLC | 05/12/2026 | 4.17 M | $14.65 M | 16.47% | 1.17% |
| NUVEEN, LLC | 04/30/2026 | 3.66 M | $12.86 M | 164.38% | 1.03% |
| HRT FINANCIAL LP | 05/14/2026 | 3.49 M | $12.24 M | -19.97% | 0.98% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 3.17 M | $11.12 M | 165.71% | 0.89% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 3.00 M | $10.52 M | -39.44% | 0.84% |
| NORTHERN TRUST CORP | 05/14/2026 | 2.88 M | $10.09 M | 11.47% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 2.78 M | $9.77 M | 1.10% | 0.78% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 2.65 M | $9.28 M | 71.90% | 0.74% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.61 M | $9.17 M | -16.92% | 0.73% |
| JPMORGAN CHASE & CO | 05/13/2026 | 2.50 M | $8.30 M | -16.69% | 0.70% |
| MARSHALL WACE, LLP | 05/15/2026 | 2.36 M | $8.27 M | 100.00% | 0.66% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 2.18 M | $7.67 M | 100.00% | 0.61% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.10 M | $7.37 M | -75.58% | 0.59% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 2.07 M | $7.27 M | 3.92% | 0.58% |
| ORION INVESTMENT CO | 05/12/2026 | 2.07 M | $7.25 M | 11.24% | 0.58% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2026 | 2.06 M | $7.21 M | 28.83% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.99 M | $6.99 M | 202.14% | 0.56% |
| UBS GROUP AG | 05/05/2026 | 1.92 M | $6.73 M | 150.83% | 0.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.71 M | $6.00 M | 1.06% | 0.48% |
| KNOTT DAVID M JR | 05/14/2026 | 1.60 M | $5.62 M | 100.00% | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/15/2026 | 1.51 M | $5.32 M | 6.30% | 0.42% |
| B GROUP, INC. | 05/15/2026 | 1.50 M | $5.27 M | 0.00% | 0.42% |
| INVESCO LTD. | 05/12/2026 | 1.42 M | $4.99 M | 13.63% | 0.40% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.29 M | $4.53 M | 127.59% | 0.36% |
| C WORLDWIDE GROUP HOLDING A/S | 05/06/2026 | 1.26 M | $4.42 M | 0.00% | 0.35% |
| MIRADOR CAPITAL PARTNERS LP | 04/08/2026 | 1.07 M | $3.77 M | 3.74% | 0.30% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 1.03 M | $3.62 M | 4,028.51% | 0.29% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 1.02 M | $3.59 M | 100.00% | 0.29% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 1.00 M | $3.51 M | 100.00% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 956.78 K | $3.36 M | 0.14% | 0.27% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 914.45 K | $3.21 M | 0.00% | 0.26% |
| SECTOR GAMMA AS | 05/07/2026 | 900.00 K | $3.16 M | 100.00% | 0.25% |
| CITADEL ADVISORS LLC | 05/15/2026 | 759.00 K | $2.66 M | 24.92% | 0.21% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 734.96 K | $2.58 M | 6.45% | 0.21% |
| QVT FINANCIAL LP | 05/15/2026 | 678.56 K | $2.38 M | 0.00% | 0.19% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 644.30 K | $2.26 M | 100.00% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iovance Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 386 institutional investors and hedge funds held shares of Iovance Biotherapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 31.08 M
MHR FUND MANAGEMENT LLC: 28.97 M
STATE STREET CORP: 17.45 M
TWO SIGMA INVESTMENTS, LP: 13.69 M
MILLENNIUM MANAGEMENT LLC: 9.41 M
GOLDMAN SACHS GROUP INC: 8.76 M
75.28% of Iovance Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 306.35 M shares in the last 24 months. This purchase volume represents approximately $1.66 B in transactions.